John A. Wos

750 total citations
34 papers, 565 citations indexed

About

John A. Wos is a scholar working on Molecular Biology, Organic Chemistry and Endocrine and Autonomic Systems. According to data from OpenAlex, John A. Wos has authored 34 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Organic Chemistry and 7 papers in Endocrine and Autonomic Systems. Recurrent topics in John A. Wos's work include Receptor Mechanisms and Signaling (8 papers), Regulation of Appetite and Obesity (7 papers) and Biochemical Analysis and Sensing Techniques (7 papers). John A. Wos is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Regulation of Appetite and Obesity (7 papers) and Biochemical Analysis and Sensing Techniques (7 papers). John A. Wos collaborates with scholars based in United States, Netherlands and Germany. John A. Wos's co-authors include José Méndez-Andino, John C. Martin, Paul R. Brodfuehrer, Muzammil M. Mansuri, John E. Starrett, David R. Tortolani, Raymond L. Funk, Henry G. Howell, K. Bhavani and Biswanath De and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

John A. Wos

33 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John A. Wos United States	13	285	249	93	87	81	34	565
Huiqiang Zhou United States	14	200 0.7×	309 1.2×	59 0.6×	40 0.5×	57 0.7×	21	540
Laurent Gavara France	14	237 0.8×	181 0.7×	48 0.5×	25 0.3×	44 0.5×	32	453
Dulce Garrido United States	11	183 0.6×	222 0.9×	31 0.3×	36 0.4×	38 0.5×	18	427
Ronald G. Sherrill United States	13	343 1.2×	224 0.9×	27 0.3×	196 2.3×	22 0.3×	19	629
Andrew S. Judd United States	13	290 1.0×	233 0.9×	62 0.7×	10 0.1×	60 0.7×	25	557
Weixu Zhai United States	13	227 0.8×	230 0.9×	26 0.3×	18 0.2×	15 0.2×	25	450
Christopher P. Laudeman United States	10	64 0.2×	188 0.8×	21 0.2×	125 1.4×	44 0.5×	15	409
Malcolm J. Kavarana United States	11	53 0.2×	262 1.1×	71 0.8×	10 0.1×	98 1.2×	14	452
Xuyuan Gu United States	13	266 0.9×	259 1.0×	58 0.6×	5 0.1×	61 0.8×	22	409
Ian D. Collier United Kingdom	12	106 0.4×	192 0.8×	9 0.1×	44 0.5×	28 0.3×	19	448

Countries citing papers authored by John A. Wos

Since Specialization

Citations

This map shows the geographic impact of John A. Wos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Wos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Wos more than expected).

Fields of papers citing papers by John A. Wos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Wos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Wos. The network helps show where John A. Wos may publish in the future.

Co-authorship network of co-authors of John A. Wos

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Wos. A scholar is included among the top collaborators of John A. Wos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Wos. John A. Wos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kullmann, F. Aura, Brian J. Limberg, Debra E. Artim, et al.. (2009). Effects of β3-Adrenergic Receptor Activation on Rat Urinary Bladder Hyperactivity Induced by Ovariectomy. Journal of Pharmacology and Experimental Therapeutics. 330(3). 704–717. 36 indexed citations

Wos, John A., Martin E. Dowty, Wei Ji, et al.. (2007). Small-Molecule Melanin-Concentrating Hormone-1 Receptor Antagonists Require Brain Penetration for Inhibition of Food Intake and Reduction in Body Weight. Journal of Pharmacology and Experimental Therapeutics. 324(1). 206–213. 10 indexed citations

Méndez-Andino, José & John A. Wos. (2007). MCH-R1 antagonists: what is keeping most research programs away from the clinic?. Drug Discovery Today. 12(21-22). 972–979. 47 indexed citations

Wang, Yili, Steven V. O’Neil, John A. Wos, et al.. (2006). Synthesis and evaluation of unsaturated caprolactams as interleukin-1β converting enzyme (ICE) inhibitors. Bioorganic & Medicinal Chemistry. 15(3). 1311–1322. 11 indexed citations

Meyers, Kenneth M., Nicholas Kim, José Méndez-Andino, et al.. (2006). Aminomethyl tetrahydronaphthalene biphenyl carboxamide MCH-R1 antagonists—Increasing selectivity over hERG. Bioorganic & Medicinal Chemistry Letters. 17(3). 814–818. 13 indexed citations

Meyers, Kenneth M., José Méndez-Andino, Anny‐Odile Colson, et al.. (2006). Novel pyrazolopiperazinone- and pyrrolopiperazinone-based MCH-R1 antagonists. Bioorganic & Medicinal Chemistry Letters. 17(3). 657–661. 7 indexed citations

Tian, Xinrong, Rajesh Mishra, Xiaoyan Hu, et al.. (2006). Design and synthesis of potent and selective 1,3,4-trisubstituted-2-oxopiperazine based melanocortin-4 receptor agonists. Bioorganic & Medicinal Chemistry Letters. 16(17). 4668–4673. 19 indexed citations

O’Neil, Steven V., Yili Wang, Michael C. Laufersweiler, et al.. (2006). Synthesis and evaluation of novel 1-(2-acylhydrazinocarbonyl)-cycloalkyl carboxamides as interleukin-1β converting enzyme (ICE) inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(16). 4233–4236. 4 indexed citations

Kim, Nick, Kenneth M. Meyers, José Méndez-Andino, et al.. (2006). Identification of substituted 4-aminopiperidines and 3-aminopyrrolidines as potent MCH-R1 antagonists for the treatment of obesity. Bioorganic & Medicinal Chemistry Letters. 16(20). 5445–5450. 9 indexed citations

10.

Warshakoon, Namal C., Wei Ji, José Méndez-Andino, et al.. (2006). Design and synthesis of substituted quinolines as novel and selective melanin concentrating hormone antagonists as anti-obesity agents. Bioorganic & Medicinal Chemistry Letters. 16(19). 5207–5211. 57 indexed citations

11.

Méndez-Andino, José, Anny‐Odile Colson, Kenneth M. Meyers, et al.. (2006). The efficacy and cardiac evaluation of aminomethyl tetrahydronaphthalene ketopiperazines: A novel class of potent MCH-R1 antagonists. Bioorganic & Medicinal Chemistry. 15(5). 2092–2105. 7 indexed citations

12.

Meyers, Kenneth M., José Méndez-Andino, Anny‐Odile Colson, et al.. (2006). Aminomethyl tetrahydronaphthalene ketopiperazine MCH-R1 antagonists—Increasing selectivity over hERG. Bioorganic & Medicinal Chemistry Letters. 17(3). 819–822. 5 indexed citations

13.

Ellis, Christopher D., Michael C. Laufersweiler, Steven V. O’Neil, et al.. (2006). Synthesis and evaluation of thiazepines as interleukin-1β converting enzyme (ICE) inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(18). 4728–4732. 11 indexed citations

14.

Laufersweiler, Michael C., Yili Wang, Maureen K. Suchanek, et al.. (2005). Synthesis and evaluation of tricyclic pyrrolopyrimidinones as dipeptide mimetics: Inhibition of interleukin-1β-converting enzyme. Bioorganic & Medicinal Chemistry Letters. 15(19). 4322–4326. 9 indexed citations

15.

Tian, Xinrong, et al.. (2005). Synthesis of Tic-d-Phe Ψ[CH2–CH2] isostere and its use in the development of melanocortin receptor agonists. Bioorganic & Medicinal Chemistry Letters. 16(6). 1721–1725. 11 indexed citations

16.

Ellis, Christopher D., Michael C. Laufersweiler, Steven V. O’Neil, et al.. (2005). Discovery of novel conformationally restricted diazocan peptidomimetics as inhibitors of interleukin-1β synthesis. Bioorganic & Medicinal Chemistry Letters. 15(19). 4291–4294. 18 indexed citations

17.

Milbank, Jared B. J., Glen E. Mieling, Robin L. Cooper, et al.. (2001). Synthesis and Biological Evaluation of Prostaglandin-F Alkylphosphinic Acid Derivatives as Bone Anabolic Agents for the Treatment of Osteoporosis.. Journal of Medicinal Chemistry. 44(24). 4307–4307.

18.

Wang, Yili, et al.. (2000). The Synthesis and Human FP Receptor Binding Affinity of 13,14-Dihydro Prostaglandin F1.ALPHA. Sulfonamides. Potential Treatments for Osteoporosis.. Chemical and Pharmaceutical Bulletin. 48(9). 1332–1337. 25 indexed citations

19.

deLong, Mitchell A., et al.. (2000). Synthesis and in vitro evaluation of human FP-receptor selective prostaglandin analogues. Bioorganic & Medicinal Chemistry Letters. 10(14). 1519–1522. 5 indexed citations

20.

Wang, Yili, John A. Wos, Mitchell A. deLong, et al.. (2000). Design and Synthesis of 13,14-Dihydro Prostaglandin F_1α Analogues as Potent and Selective Ligands for the Human FP Receptor. Journal of Medicinal Chemistry. 43(5). 945–952. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact